| Dr Jose Antonio Berllingeri, MD | |
|
4837 Ave Isla Verde, Apt. 1109, Carolina, PR 00979-5418 | |
| (787) 268-3147 | |
| (787) 268-3147 |
| Full Name | Dr Jose Antonio Berllingeri |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 4837 Ave Isla Verde, Carolina, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407175383 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 2949 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jose Antonio Berllingeri, MD 4837 Ave Isla Verde, Apt. 1109, Carolina, PR 00979-5418 Ph: (787) 268-3147 | Dr Jose Antonio Berllingeri, MD 4837 Ave Isla Verde, Apt. 1109, Carolina, PR 00979-5418 Ph: (787) 268-3147 |
News Archive
LGBT Health, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers, launching in fall 2013, presents a timely and in-depth perspective on several key controversies surrounding gender diagnoses.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced today that it intends to offer units consisting of shares of its common stock and warrants to purchase shares of its common stock in a public offering. Maxim Group LLC is acting as the sole book-running manager for this offering, with Ladenburg Thalmann & Co. Ltd. as co-manager.
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
FDA announces new policy and regulatory developments to strengthen the Agency's oversight and protection of patients in clinical trials and the integrity of resulting data in an effort to modernize the agency's approach to bioresearch monitoring as part of the Critical Path Initiative.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.
› Verified 4 days ago
Dr. Yarisma Frometa Pastrana, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5757 Ave Isla Verde, Carolina, PR 00979 Phone: 203-824-9610 | |
Mr. Juan A Torres Torres, M.D. Radiology Medicare: Medicare Enrolled Practice Location: Carolina Ct & Breast Clinic, Carolina Shopping Court Suite 023a, Carolina, PR 00985 Phone: 787-257-0677 Fax: 787-257-3030 | |
Carmen S Caban Espinosa, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Carolina Ct & Breast Clinic, Carolina Shopping Court Suite 023a, Carolina, PR 00985 Phone: 787-257-0677 Fax: 787-257-3030 | |
Gabriela De La Vega Muns, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4531 Ave Isla Verde Apt 1401, Carolina, PR 00979 Phone: 787-645-9537 | |
Dr. Wanda Liz Rodriguez-galarza, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1503 Marbella St., Mansiones Vistamar Marina, Carolina, PR 00983 Phone: 787-257-9586 Fax: 787-257-9586 | |
Dr. Enrique Agustin Padro I, M.D. Radiology Medicare: Medicare Enrolled Practice Location: E17 Calle Malaga, Vistamar Marina, Carolina, PR 00983 Phone: 787-768-6661 Fax: 787-757-6935 |